Australia’s AOD landscape: Reflections on 15 years serving on the Board of a national research institute

June 2024
This edition's opinion piece is written by retiring NDRI Board Chair Adjunct Professor Michael Moore, who reflects on Australia's AOD landscape and informing and influencing policy makers.
Read more
December 2019

Up in smoke: The extraordinary cost of smoking to Australia

Tobacco is responsible for the preventable deaths of 20,000 Australians each year, and the cost to them and to the wider community is high.
October 2019

Celebrating success

There’s a tendency in the alcohol and drug sector, as with many areas of health and human services, to focus on the negative and the harms.
August 2019

Understanding the impact of opioid agonist treatment in reducing crime

In a recently published study, we examined the link between opioid agonist treatment (OAT) and crime in nearly 11,000 people in New South Wales (NSW).
June 2019

Beyond ‘pill testing’: Calling for appropriate event health care services at music festivals

Professor Simon Lenton, NDRI
April 2019

Why focusing on the AOD workforce is important

Dr Natalie Skinner, Senior Research Fellow, NCETA
February 2019

How is Australia responding to the pharmaceutical opioid problem?

Dr Gabrielle Campbell, NHMRC Australian Public Health Early Career Fellow at NDARC, UNSW.
December 2018

Cannabis regulation: Profit versus public health

Professor Simon Lenton, Director, NDRI
October 2018

Clinical practice guidelines: Questions of relevance, reliability and utility explored

Professor Ann Roche, Director, NCETA
August 2018

Can we improve processes for engaging communities and services in research?

Professor Anthony Shakeshaft, National Drug and Alcohol Research Centre, UNSW Sydney
June 2018

Renewed interest in psychedelics as potentially useful therapeutic agents

NDRI Adjunct Research Fellow Dr Stephen Bright shares his views about psychedelic research programs that have been initiated by several prestigious in

Pages